SUGAR LAND--January 21, 2022--Researched by Industrial Info Resources (Sugar Land, Texas)--North America's Pharmaceutical & Biotech Industry opened 152 new plants in 2021. Comprising brownfield and grassroot facilities, the sites represent a potential total investment value of $8 billion, when including original construction costs with any planned expansions or additional phases. Interestingly, none of the plants were sourced from traditional "big pharma" companies.
This Premium Article can be purchased individually or as part of a subscription
Subscription Type:
Articles related to this company
